Other explanations for the controversial results in different studies on the association between the prothrombin G20210A polymorphism and CAD may be the existence of variations in the frequency of other genetic and environmental risk factors in various populations and variations in selection criteria in different studies. The gene discussed is F2; the disease is coronary artery disorder.